124 related articles for article (PubMed ID: 36534890)
1. Repurposing of 5-nitrofuran-3,5-disubstituted isoxazoles: A thriving scaffold to antitrypanosomal agents.
Carvalho DB; das Neves AR; Portapilla GB; Soares O; Santos LBB; Oliveira JRS; Vianna LS; Judice WAS; Cardoso IA; Luccas PH; Nonato MC; Lopes NP; de Albuquerque S; Baroni ACM
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200472. PubMed ID: 36534890
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, antileishmanial, and antifungal biological evaluation of novel 3,5-disubstituted isoxazole compounds based on 5-nitrofuran scaffolds.
Trefzger OS; Barbosa NV; Scapolatempo RL; das Neves AR; Ortale MLFS; Carvalho DB; Honorato AM; Fragoso MR; Shuiguemoto CYK; Perdomo RT; Matos MFC; Chang MR; Arruda CCP; Baroni ACM
Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900241. PubMed ID: 31840866
[TBL] [Abstract][Full Text] [Related]
3. Investigating the structure-activity relationships of N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds.
Palace-Berl F; Pasqualoto KFM; Zingales B; Moraes CB; Bury M; Franco CH; da Silva Neto AL; Murayama JS; Nunes SL; Silva MN; Tavares LC
Eur J Med Chem; 2018 Jan; 144():29-40. PubMed ID: 29247858
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; O'Shea IP; Wilkinson SR; Kaiser M; Chatelain E; Ioset JR
Bioorg Med Chem; 2015 Oct; 23(19):6467-76. PubMed ID: 26344593
[TBL] [Abstract][Full Text] [Related]
5. Rational design of nitrofuran derivatives: Synthesis and valuation as inhibitors of Trypanosoma cruzi trypanothione reductase.
Arias DG; Herrera FE; Garay AS; Rodrigues D; Forastieri PS; Luna LE; Bürgi MD; Prieto C; Iglesias AA; Cravero RM; Guerrero SA
Eur J Med Chem; 2017 Jan; 125():1088-1097. PubMed ID: 27810595
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Antitrypanosomal Activity of 1,4-Disubstituted Triazole Compounds Based on a 2-Nitroimidazole Scaffold: a Structure-Activity Relationship Study.
Assunção ELF; Carvalho DB; das Neves AR; Kawasoko Shiguemotto CY; Portapilla GB; de Albuquerque S; Baroni ACM
ChemMedChem; 2020 Nov; 15(21):2019-2028. PubMed ID: 32729242
[TBL] [Abstract][Full Text] [Related]
7. Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies.
Palos I; Lara-Ramirez EE; Lopez-Cedillo JC; Garcia-Perez C; Kashif M; Bocanegra-Garcia V; Nogueda-Torres B; Rivera G
Molecules; 2017 Jun; 22(6):. PubMed ID: 28629155
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis.
da Rosa R; de Moraes MH; Zimmermann LA; Schenkel EP; Steindel M; Bernardes LSC
Eur J Med Chem; 2017 Mar; 128():25-35. PubMed ID: 28152426
[TBL] [Abstract][Full Text] [Related]
9. Novel nitroimidazole derivatives evaluated for their trypanocidal, cytotoxic, and genotoxic activities.
do Vale Chaves E Mello F; Castro Salomão Quaresma BM; Resende Pitombeira MC; Araújo de Brito M; Farias PP; Lisboa de Castro S; Salomão K; Silva de Carvalho A; Oliveira de Paula JI; de Brito Nascimento S; Peixoto Cupello M; Paes MC; Boechat N; Felzenszwalb I
Eur J Med Chem; 2020 Jan; 186():111887. PubMed ID: 31787363
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of isoxazolyl-sulfonamides: A non-cytotoxic scaffold active against Trypanosoma cruzi, Leishmania amazonensis and Herpes Simplex Virus.
da Rosa R; Zimmermann LA; de Moraes MH; Schneider NFZ; Schappo AD; Simões CMO; Steindel M; Schenkel EP; Bernardes LSC
Bioorg Med Chem Lett; 2018 Nov; 28(20):3381-3384. PubMed ID: 30194008
[TBL] [Abstract][Full Text] [Related]
11. Designing and exploring active N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients.
Palace-Berl F; Pasqualoto KF; Jorge SD; Zingales B; Zorzi RR; Silva MN; Ferreira AK; de Azevedo RA; Teixeira SF; Tavares LC
Eur J Med Chem; 2015; 96():330-9. PubMed ID: 25899337
[TBL] [Abstract][Full Text] [Related]
12. Molecular design aided by random forests and synthesis of potent trypanocidal agents as cruzain inhibitors for Chagas disease treatment.
de Albuquerque S; Cianni L; de Vita D; Duque C; Gomes ASM; Gomes P; Laughton C; Leitão A; Montanari CA; Montanari R; Ribeiro JFR; da Silva JS; Teixeira C
Chem Biol Drug Des; 2020 Sep; 96(3):948-960. PubMed ID: 33058457
[TBL] [Abstract][Full Text] [Related]
13. Structure-Based Virtual Screening and In Vitro Evaluation of New
Herrera-Mayorga V; Lara-Ramírez EE; Chacón-Vargas KF; Aguirre-Alvarado C; Rodríguez-Páez L; Alcántara-Farfán V; Cordero-Martínez J; Nogueda-Torres B; Reyes-Espinosa F; Bocanegra-García V; Rivera G
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30970549
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and antitrypanosomatid activity of 2-nitroimidazole-3,5-disubstituted isoxazole compounds based on benznidazole.
Carvalho DB; Costa PAN; Portapilla GB; das Neves AR; Shiguemoto CYK; Pelizaro BI; Silva F; Piranda EM; Arruda CCP; Gaspari PDM; Cardoso IA; Luccas PH; Nonato MC; Lopes NP; de Albuquerque S; Baroni ACM
Eur J Med Chem; 2023 Nov; 260():115451. PubMed ID: 37573209
[TBL] [Abstract][Full Text] [Related]
15. Nitrofuran drugs as common subversive substrates of Trypanosoma cruzi lipoamide dehydrogenase and trypanothione reductase.
Blumenstiel K; Schöneck R; Yardley V; Croft SL; Krauth-Siegel RL
Biochem Pharmacol; 1999 Dec; 58(11):1791-9. PubMed ID: 10571254
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of New Thiosemicarbazones and Semicarbazones Containing the 1,2,3-1H-triazole-isatin Scaffold: Trypanocidal, Cytotoxicity, Electrochemical Assays, and Molecular Docking.
Silva BNM; Sales Junior PA; Romanha AJ; Murta SMF; Lima CHS; Albuquerque MG; D'Elia E; Rodrigues JGA; Ferreira VF; Silva FC; Pinto AC; Silva BV
Med Chem; 2019; 15(3):240-256. PubMed ID: 30332972
[TBL] [Abstract][Full Text] [Related]
17. Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease.
de Oliveira Rezende Júnior C; Martinez PDG; Ferreira RAA; Koovits PJ; Miranda Soares B; Ferreira LLG; Michelan-Duarte S; Chelucci RC; Andricopulo AD; Matheeussen A; Van Pelt N; Caljon G; Maes L; Campbell S; Kratz JM; Mowbray CE; Dias LC
Eur J Med Chem; 2023 Jan; 246():114925. PubMed ID: 36459758
[TBL] [Abstract][Full Text] [Related]
18. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain.
Espíndola JW; Cardoso MV; Filho GB; Oliveira E Silva DA; Moreira DR; Bastos TM; Simone CA; Soares MB; Villela FS; Ferreira RS; Castro MC; Pereira VR; Murta SM; Sales Junior PA; Romanha AJ; Leite AC
Eur J Med Chem; 2015 Aug; 101():818-35. PubMed ID: 26231082
[TBL] [Abstract][Full Text] [Related]
20. Aryl ureas represent a new class of anti-trypanosomal agents.
Du X; Hansell E; Engel JC; Caffrey CR; Cohen FE; McKerrow JH
Chem Biol; 2000 Sep; 7(9):733-42. PubMed ID: 10980453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
